By Charles S. Alovisetti, Partner
Sep 6, 2019
The first post in our “Budding Companies: Forming Cannabis Startups” series, where we explore different issues involved in the formation of new marijuana and hemp companies. In this post we will focus on entity choice and taxation.
By Charles S. Alovisetti, Partner; Jessica Scardina, Senior Associate Attorney; and Ben Leonard, Associate Attorney
Aug 26, 2019
New guidance from the Colorado MED clarifies that companies and investors can begin taking advantage of HB 1090’s more flexible regulatory structure immediately.
By Shawn Hauser, Partner; Michelle Bodian, Senior Associate Attorney; Caitlin Wightman, Law Clerk
Aug 23, 2019
Key takeaways from the U.S. Senate Agriculture Committee’s historic hearing on Thursday, July 25, 2019, where they discussed hemp production and related issues ahead of the release of federal rules.
By Charles Alovisetti, Partner; Jennifer Cabrera, Counsel; and Sahar Ayinehsazian, Associate Attorney
Aug 2, 2019
Here's a look into New Jersey Assembly Bill 20, which, once implemented, will greatly expand patients’ access to medical cannabis.
By Shawn Hauser, Partner; Courtney Barnes, Associate Attorney; Caitlin Wightman, Law Clerk
Jul 30, 2019
Here are five reasons why Texas is positioned to become one of the top hemp producers and researchers in the US, and potentially internationally.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.